Ovintiv Inc. (DE) Stock 12‑Month Price Target Raised to $80.36, Implies 21% Upside

What happened

Estimates from 25 analysts put Ovintiv Inc.’s average 12-month share price target at $80.36, up from $79.8. Based on the Nov. 3 closing price, the revised target indicates about 21% potential upside. Among 29 analysts, the consensus rating remains Buy: 23 Buys, six Holds and no Sells.

Confirmed

Global impact / market context

The higher target may make Ovintiv shares more attractive to investors, potentially supporting demand and the share price. That could lower the cost of raising equity funding for the company, but the article gives no evidence of changed operations, spending plans, revenue or costs, and the target is not a promised return.

Analyst inference

Analysts’ forecasts range from $65 to $97 per share, a broad spread that signals differing views of Ovintiv’s value. The average rose only from $79.8 to $80.36, and its stated 21% upside depends on the Nov. 3 closing price rather than guaranteeing a gain.

Confirmed

What to watch

1. Future analyst target revisions could show whether the $80.36 average continues rising or reverses; the article provides no operating results explaining the increase. Analyst inference
2. Watch whether the rating mix changes from 23 Buys, six Holds and no Sells among 29 covering analysts, as shifts could alter investor expectations and share demand. Analyst inference
3. Compare Ovintiv’s share price with the updated target over time; the stated 21% potential upside is based on the Nov. 3 closing price, not a guaranteed gain. Confirmed

Evidence

• Original source link unavailable